Cargando…

Peroxisome Proliferator-Activated Receptor Gamma Agonist Attenuates Liver Fibrosis by Several Fibrogenic Pathways in an Animal Model of Cholestatic Fibrosis

PURPOSE: Peroxisome proliferator-activated receptor gamma (PPAR-γ) has a key role in hepatic fibrogenesis by virtue of its effect on the hepatic stellate cells (HSCs). Although many studies have shown that PPAR-γ agonists inhibit liver fibrosis, the mechanism remains largely unclear, especially rega...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alatas, Fatima Safira, Matsuura, Toshiharu, Pudjiadi, Antonius Hocky, Wijaya, Stephanie, Taguchi, Tomoaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354870/ https://www.ncbi.nlm.nih.gov/pubmed/32704495 http://dx.doi.org/10.5223/pghn.2020.23.4.346

Ejemplares similares

Modified Puestow Procedure for Chronic Pancreatitis in a Child Due to Annular Pancreas and Duodenal Duplication: A Case Report
por: Alatas, Fatima Safira, et al.
Publicado: (2020)

Serum NT-Pro-BNP versus Noninvasive Bedside Inotropic Index in Paediatric Shock: A Contest of Myocardial Performance in Response to Fluid Loading
por: Pudjiadi, Antonius Hocky, et al.
Publicado: (2021)

Correlation between syndecan-1 level and PELOD-2 score and mortality in pediatric sepsis
por: Pudjiadi, Antonius Hocky, et al.
Publicado: (2021)

Diagnostic challenges of hypoganglionosis based on immunohistochemical method
por: Alatas, Fatima Safira, et al.
Publicado: (2023)

Echovirus-7 Infection in Children with Unusual Severe Manifestation: A Case Report
por: Pudjiadi, Antonius Hocky, et al.
Publicado: (2021)

The Role of Pretransplant Infections in Pediatric Receiving LDLT in Indonesia: A 7-y Retrospective Study
por: Alatas, Fatima Safira, et al.
Publicado: (2023)

In vivo hepatogenic capacity and therapeutic potential of stem cells from human exfoliated deciduous teeth in liver fibrosis in mice
por: Yamaza, Takayoshi, et al.
Publicado: (2015)

Dysregulated Proinflammatory and Fibrogenic Phenotype of Fibroblasts in Cystic Fibrosis
por: Huaux, François, et al.
Publicado: (2013)

The Agonists of Peroxisome Proliferator-Activated Receptor-γ for Liver Fibrosis
por: Li, Jingjing, et al.
Publicado: (2021)

Fibrosis in Autoimmune and Cholestatic Liver Disease
por: Penz-Österreicher, Melitta, et al.
Publicado: (2011)

Determining pediatric fluid responsiveness by stroke volume variation analysis using ICON® electrical cardiometry and ultrasonic cardiac output monitor: A cross-sectional study
por: Kadafi, Kurniawan Taufiq, et al.
Publicado: (2020)

Inferior Vena Cava/Abdominal Aorta Ratio as a Guide for Fluid Resuscitation
por: Kusumastuti, Neurinda Permata, et al.
Publicado: (2021)

Combination of a peroxisome proliferator‐activated receptor‐gamma agonist and an angiotensin II receptor blocker attenuates myocardial fibrosis and dysfunction in type 2 diabetic rats
por: Shim, Chi Young, et al.
Publicado: (2013)

The Correlations of Human Atrial Natriuretic Peptide on Cardiac Function and Hemodynamics in Pediatric Septic Shock
por: Setyaningtyas, Arina, et al.
Publicado: (2022)

Cytochrome P450 Omega-Hydroxylase 4a14 Attenuates Cholestatic Liver Fibrosis
por: Li, Sha, et al.
Publicado: (2021)

Upregulation of cadherin‐11 contributes to cholestatic liver fibrosis
por: Wu, Bo, et al.
Publicado: (2022)

miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis
por: Liu, Gang, et al.
Publicado: (2010)

IL-8 mediates idiopathic pulmonary fibrosis mesenchymal progenitor cell fibrogenicity
por: Yang, Libang, et al.
Publicado: (2018)

Radiation Induces Pulmonary Fibrosis by Promoting the Fibrogenic Differentiation of Alveolar Stem Cells
por: Wang, Lu-Kai, et al.
Publicado: (2020)

Lobeglitazone, a Novel Peroxisome Proliferator-Activated Receptor γ Agonist, Attenuates Renal Fibrosis Caused by Unilateral Ureteral Obstruction in Mice
por: Bae, Kwi-Hyun, et al.
Publicado: (2017)

Identification of P-Rex1 as an anti-inflammatory and anti-fibrogenic target for pulmonary fibrosis
por: Liang, Qing, et al.
Publicado: (2016)

Mesenchymal Stem/Stromal Cells in Progressive Fibrogenic Involvement and Anti-Fibrosis Therapeutic Properties
por: Li, Chenghai, et al.
Publicado: (2022)

Casein Kinase 1δ/ε Inhibitor, PF670462 Attenuates the Fibrogenic Effects of Transforming Growth Factor-β in Pulmonary Fibrosis
por: Keenan, Christine R., et al.
Publicado: (2018)

Ultrasound Assisted a Peroxisome Proliferator-Activated Receptor (PPAR)γ Agonist-Loaded Nanoparticle-Microbubble Complex to Attenuate Renal Interstitial Fibrosis
por: Wei, Shuping, et al.
Publicado: (2020)

The role of Mesothelin signaling in Portal Fibroblasts in the pathogenesis of cholestatic liver fibrosis
por: Fuji, Hiroaki, et al.
Publicado: (2021)

Targeting hepatic oxidative stress rescues bone loss in liver fibrosis
por: Sonoda, Soichiro, et al.
Publicado: (2022)

GIV/Girdin is a central hub for pro-fibrogenic signalling networks during liver fibrosis
por: Lopez-Sanchez, Inmaculada, et al.
Publicado: (2014)

Inhibition of a novel fibrogenic factor Tl1a reverses established colonic fibrosis
por: Shih, David Q, et al.
Publicado: (2014)

miR-185 Inhibits Fibrogenic Activation of Hepatic Stellate Cells and Prevents Liver Fibrosis
por: Zhou, Li, et al.
Publicado: (2017)

α-smooth muscle actin is not a marker of fibrogenic cell activity in skeletal muscle fibrosis
por: Zhao, Wanming, et al.
Publicado: (2018)

MiR-424/TGIF2-Mediated Pro-Fibrogenic Responses in Oral Submucous Fibrosis
por: Chou, Ming-Yung, et al.
Publicado: (2023)

A model study for the manufacture and validation of clinical-grade deciduous dental pulp stem cells for chronic liver fibrosis treatment
por: Iwanaka, Tsuyoshi, et al.
Publicado: (2020)

Geranylgeranylacetone attenuates fibrogenic activity and induces apoptosis in cultured human hepatic stellate cells and reduces liver fibrosis in carbon tetrachloride-treated mice
por: Senoo, Takemasa, et al.
Publicado: (2018)

Anti-fibrogenic effect of PPAR-γ agonists in human intestinal myofibroblasts
por: Koo, Jun Bon, et al.
Publicado: (2017)

Epidermal growth factor signaling protects from cholestatic liver injury and fibrosis
por: Svinka, Jasmin, et al.
Publicado: (2016)

Chenodeoxycholic acid activates NLRP3 inflammasome and contributes to cholestatic liver fibrosis
por: Gong, Zizhen, et al.
Publicado: (2016)

ERRγ suppression by Sirt6 alleviates cholestatic liver injury and fibrosis
por: Hao, Lihua, et al.
Publicado: (2020)

Inhibition of CBP/β‐catenin signaling ameliorated fibrosis in cholestatic liver disease
por: Kimura, Masamichi, et al.
Publicado: (2022)

Combi-Elasto Evaluation of the Degree of Liver Fibrosis in Children with Cholestatic Liver Disease
por: Li, Rina, et al.
Publicado: (2023)

Management of cardiac fibrosis in diabetic rats; the role of peroxisome proliferator activated receptor gamma (PPAR-gamma) and calcium channel blockers (CCBs)
por: Mohamad, Hoda E, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_sej38d9vi9o22gv703pj7ucfg3